Sven Henrichwark, PhD

Dr. Sven Henrichwark has over 25 years of experience in the healthcare and life science industries and is currently CEO of Fibronostics and Director of Kyberlife. He joined GE Healthcare as the Chief Medical Officer for Life Sciences (now Cytiva), then followed as General Manager, Service for GE Healthcare, and COO GE Healthcare for APAC and global commercial General Manager for GE Bioprocess. Dr. Henrichwark has also served as CEO of Echosens, Executive Vice President APAC for Avantor, and advisor or SPRIM Ventures, Ampersand Capital Partners, and Nanyang Technological University (NTU) Singapore.

Dr. Henrichwark obtained a PhD in viral immunopathology of HIV from the Pasteur Institute in Paris.